Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Qelbree for the treatment of ADHD in pediatric patients

April 6, 2021

FDA approves Vyxeos for secondary AML in pediatric patients

March 31, 2021

FDA approves Abecma for relapsed or refractory multiple myeloma

March 29, 2021

FDA approves Myrbetriq tablets and granules for neurogenic detrusor overactivity in children

March 26, 2021

Seikagaku obtains approval in Japan for Joyclu intra-articular injection

March 25, 2021

Ostabaro approved in Japan for osteoporosis in patients at high risk of fractures

March 24, 2021

Japanese MHLW approves Remitoro for relapsed or refractory PTCL and CTCL

March 24, 2021

Japanese approval of Lenvima for unresectable thymic carcinoma

March 24, 2021

Izcargo approved in Japan for the treatment of MPS II

March 24, 2021

FDA approves Zegalogue to treat severe hypoglycemia in children and adults with diabetes

March 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...